» Articles » PMID: 36685965

Machine Learning in the Development of Targeting MicroRNAs in Human Disease

Overview
Journal Front Genet
Date 2023 Jan 23
PMID 36685965
Authors
Affiliations
Soon will be listed here.
Abstract

A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA targeting therapy only through experiments is expensive and laborious, so it is essential to develop novel and efficient computational methods to narrow down the search. Recent advances in machine learning applied in biomedical informatics provide opportunities to explore miRNA-targeting drugs, thus promoting miRNA therapeutics. This review provides an overview of recent advancements in miRNA targeting therapeutic using machine learning. First, we mainly describe the basics of predicting miRNA targeting drugs, including pharmacogenomic data resources and data preprocessing. Then we present primary machine learning algorithms and elaborate their application in discovering relationships among miRNAs, drugs, and diseases. Along with the progress of miRNA targeting therapeutics, we finally analyze and discuss the current challenges and opportunities that machine learning confronts.

Citing Articles

Advancing miRNA cancer research through artificial intelligence: from biomarker discovery to therapeutic targeting.

Aswathy R, Chalos V, Suganya K, Sumathi S Med Oncol. 2024; 42(1):30.

PMID: 39688780 DOI: 10.1007/s12032-024-02579-z.


Analysis of microRNAs in response to eensis infection and their potential role in vectorial capacity.

Kumar D, Budachetri K, Rikihisa Y, Karim S Front Cell Infect Microbiol. 2024; 14:1427562.

PMID: 39086604 PMC: 11288922. DOI: 10.3389/fcimb.2024.1427562.


Analysis of microRNAs in response to eensis infection and their potential role in vectorial capacity.

Kumar D, Budachetri K, Rikihisa Y, Karim S bioRxiv. 2024; .

PMID: 38765993 PMC: 11100627. DOI: 10.1101/2024.05.03.592465.


What are the changes in the hotspots and frontiers of microRNAs in hepatocellular carcinoma over the past decade?.

Zhang L, Chen Z, Wei X, Li J, Chen G World J Clin Oncol. 2024; 15(1):145-158.

PMID: 38292666 PMC: 10823937. DOI: 10.5306/wjco.v15.i1.145.


The leading global health challenges in the artificial intelligence era.

Zaidan A Front Public Health. 2023; 11:1328918.

PMID: 38089037 PMC: 10711066. DOI: 10.3389/fpubh.2023.1328918.

References
1.
Fu L, Peng Q . A deep ensemble model to predict miRNA-disease association. Sci Rep. 2017; 7(1):14482. PMC: 5670180. DOI: 10.1038/s41598-017-15235-6. View

2.
Li J, Zhang S, Liu T, Ning C, Zhang Z, Zhou W . Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction. Bioinformatics. 2020; 36(8):2538-2546. DOI: 10.1093/bioinformatics/btz965. View

3.
Chu Y, Wang X, Dai Q, Wang Y, Wang Q, Peng S . MDA-GCNFTG: identifying miRNA-disease associations based on graph convolutional networks via graph sampling through the feature and topology graph. Brief Bioinform. 2021; 22(6). DOI: 10.1093/bib/bbab165. View

4.
Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J . Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 2016; 107(3):326-34. PMC: 4814263. DOI: 10.1111/cas.12880. View

5.
Li G, Fang T, Zhang Y, Liang C, Xiao Q, Luo J . Predicting miRNA-disease associations based on graph attention network with multi-source information. BMC Bioinformatics. 2022; 23(1):244. PMC: 9215044. DOI: 10.1186/s12859-022-04796-7. View